Mable (private company)
See something wrong or missing? Let us know
Offices:Oxford
Industry:
Biotech
Health services
Pharma
Business model:
B2B
Mable (formerly Neurolytic Healthcare) provides personalized medicine for neurological conditions, as it collects and extracts insights from a combination of genetic and biomarker data to enhance diagnosis and help clinicians decide on optimal treatment strategies for neurological conditions.
Investors:
we tracked 7 investors
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
values in USD
Investments 0
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
Belgium
Netherlands
Austria
Germany
Switzerland
Denmark
Estonia
Finland
Iceland
Latvia
Lithuania
Norway
Sweden
France
Ireland
Italy
Portugal
Spain